The importance of resistance to direct antiviral drugs in HCV infection in clinical practice, J Hepatol, vol.64, pp.486-504, 2016. ,
Hepatitis C virus resistance to direct-acting antiviral drugs in interferon-free regimens, Gastroenterology, vol.151, pp.70-86, 2016. ,
Detection of occult hepatitis C virus infection in patients who achieved a sustained virologic response to direct-acting antiviral agents for recurrent infection after liver transplantation, Gastroenterology, 2016. ,
Current and future therapies for hepatitis C virus infection, N Engl J Med, vol.368, pp.1907-1924, 2013. ,
Hepatitis C virus treatment in the real world: optimising treatment and access to therapies, Gut, vol.64, pp.1824-1857, 2015. ,
Sofosbuvir and Velpatasvir for HCV in patients with decompensated cirrhosis, N Engl J Med, vol.373, pp.2618-2646, 2015. ,
Curing chronic hepatitis C--the arc of a medical triumph, N Engl J Med, vol.370, pp.1576-1584, 2014. ,
New perspectives for preventing hepatitis C virus liver graft infection, Lancet Infect Dis, vol.16, pp.735-780, 2016. ,
Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study, Gastroenterology, vol.148, pp.100-107, 2015. ,
Impact of donor and recipient hepatitis C status in lung transplantation, Organ Procurement and Transplant Data, vol.35, pp.228-263, 2016. ,
Binding of hepatitis C virus to CD81, Science, vol.282, pp.938-979, 1998. ,
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus, EMBO J, vol.21, pp.5017-5042, 2002. ,
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry, Nature, vol.446, pp.801-806, 2007. ,
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy, Nat Med, vol.17, pp.589-95, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-00705829
Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor, Nat Med, vol.18, pp.281-286, 2012. ,
Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition, Proc Natl Acad Sci, vol.113, pp.7620-7625, 2016. ,
Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo, Hepatology, vol.48, pp.1761-1769, 2008. ,
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents, Hepatology, vol.60, pp.1508-1526, 2014. ,
Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes, Gastroenterology, vol.139, pp.953-64, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00741442
Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody, Nat Biotechnol, vol.33, pp.549-54, 2015. ,
Novel human anti-Claudin 1 monoclonal antibodies inhibit HCV infection and may synergize with anti-SRB1 mAb, J Gen Virol, vol.97, pp.82-94, 2015. ,
Discovery of anti-claudin-1 antibodies as candidate therapeutics against hepatitis C virus, J Pharmacol Exp Ther, vol.353, pp.112-130, 2015. ,
Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection, Sci Transl Med, vol.7, pp.282-331, 2015. ,
Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C, Gut, vol.64, pp.483-94, 2015. ,
Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents, PLoS Pathog, vol.10, p.1004128, 2014. ,
Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus, J Virol, vol.81, pp.12465-71, 2007. ,
The tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virus, J Virol, vol.82, pp.3555-60, 2008. ,
Isolate-dependent use of claudins for cell entry by hepatitis C virus, Hepatology, vol.59, pp.24-34, 2014. ,
Functional analysis of claudin-6 and claudin-9 as entry factors for hepatitis C virus infection of human hepatocytes by using monoclonal antibodies, J Virol, vol.87, pp.10405-10415, 2013. ,
Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations, Hepatology, vol.51, pp.1144-57, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00705657
Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites, J Immunol, vol.147, pp.1709-1728, 1991. ,
Replacing the complementarity-determining regions in a human antibody with those from a mouse, Nature, vol.321, pp.522-527, 1986. ,
Reshaping human antibodies: grafting an antilysozyme activity, Science, vol.239, pp.1534-1540, 1988. ,
Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells, J Virol, vol.83, pp.6211-6232, 2009. ,
Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C, Proc Natl Acad Sci, vol.104, pp.6025-6055, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-00395910
Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation, J Exp Med, vol.207, pp.2019-2050, 2010. ,
Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses, J Virol, vol.80, pp.5308-5328, 2006. ,
CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells, J Gen Virol, vol.90, pp.48-58, 2009. ,
A three-dimensional model to analyze drug-drug interactions, Antiviral Res, vol.14, pp.181-205, 1990. ,
Hepatitis C virus replication in mice with chimeric human livers, Nat Med, vol.7, pp.927-960, 2001. ,
Shorter waitlist times and improved graft survivals are observed in patients who accept hepatitis C virus+ renal allografts, Transplantation, vol.99, pp.1192-1198, 2015. ,
Transplanting hepatitis C-positive kidneys, N Engl J Med, vol.373, pp.303-308, 2015. ,